Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23106
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLloyd-Donald, Patryck-
dc.contributor.authorChurilov, Leonid-
dc.contributor.authorCheong, Brandon-
dc.contributor.authorBellomo, Rinaldo-
dc.contributor.authorMcCall, Peter R-
dc.contributor.authorMårtensson, Johan-
dc.contributor.authorGlassford, Neil J-
dc.contributor.authorWeinberg, Laurence-
dc.date2020-04-27-
dc.date.accessioned2020-05-05T23:59:25Z-
dc.date.available2020-05-05T23:59:25Z-
dc.date.issued2020-04-27-
dc.identifier.citationScientific Reports 2020-04-27; 10(1): 7045-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/23106-
dc.description.abstractThe TEG6S is a novel haemostasis analyser utilising resonance technology. It offers potentially greater coagulation information and ease of use, however has not been independently validated in a clinical setting. We aimed to determine if the TEG6S is reliable between devices and across time points. We performed a prospective observational study with ethical approval. For interdevice reliability, we performed simultaneous analysis on two TEG6S devices on 25 adult ICU patients. For time point reliability, we performed repeated sampling across five different time points on 15 adult participants. Blood was collected with informed consent, or as standard care, before four-channel citrated kaolin analysis. We observed almost perfect interdevice reliability across all TEG parameters. The Lin's concordance correlation coefficients (95% CI, major axis regression slope, intercept) were R-time: 0.96 (0.92-0.99, 0.88, 0.57); K-time: 0.93 (0.87-0.98, 1.07, 0.00); Alpha Angle: 0.87 (0.78-0.96, 1.20, -14.10); Maximum Amplitude: 0.99 (0.98-0.99, 1.02, -1.38); Clot Lysis: 0.89 (0.82-0.97, 1.20, 0.07). Additionally, we observed moderate-to-high reliability across time points. Demonstrating almost perfect agreement across different devices and moderate-to-high reliability across multiple time points, suggests the TEG6S platform can be used with haemostatic accuracy and generalisability. This has potentially significant implications for clinical practice and multi-site research programs.-
dc.language.isoeng-
dc.titleAssessing TEG6S reliability between devices and across multiple time points: A prospective thromboelastography validation study.-
dc.typeJournal Article-
dc.identifier.journaltitleScientific Reports-
dc.identifier.affiliationDepartment of Intensive Care, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Anaesthesia, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Surgery, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Perioperative Medicine and Intensive Care Medicine, Karolinska University Hospital, Solna, and Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77, Stockholm, Sweden-
dc.identifier.doi10.1038/s41598-020-63964-y-
dc.identifier.orcid0000-0002-9807-6606-
dc.identifier.orcid0000-0002-1650-8939en
dc.identifier.orcid0000-0001-8739-7896en
dc.identifier.orcid0000-0001-7403-7680en
dc.identifier.orcid0000-0001-7403-7680-
dc.identifier.pubmedid32341418-
dc.type.austinJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Jan 23, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.